0001140361-19-018071.txt : 20191007 0001140361-19-018071.hdr.sgml : 20191007 20191007191559 ACCESSION NUMBER: 0001140361-19-018071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191007 FILED AS OF DATE: 20191007 DATE AS OF CHANGE: 20191007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coiante Scott M CENTRAL INDEX KEY: 0001608536 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 191141663 MAIL ADDRESS: STREET 1: 101 POOR FARM ROAD 3RD FLOOR CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 form4.xml FORM 4 X0306 4 2019-10-07 0001781983 Aprea Therapeutics, Inc. APRE 0001608536 Coiante Scott M 535 BOYLSTON STREET BOSTON MA 02116 true SVP, Chief Financial Officer Common Stock 2019-10-07 4 P 0 2500 15 A 2500 D Stock Option (right to Buy) 15 2019-10-07 4 A 0 150824 0 A 2029-10-02 Common Stock 150824 150824 D Twenty-five percent of these options vest on October 2, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions. /s/ Scott M. Coiante 2019-10-07